These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

376 related articles for article (PubMed ID: 24457088)

  • 1. Design and synthesis of N₁-aryl-benzimidazoles 2-substituted as novel HIV-1 non-nucleoside reverse transcriptase inhibitors.
    Monforte AM; Ferro S; De Luca L; Lo Surdo G; Morreale F; Pannecouque C; Balzarini J; Chimirri A
    Bioorg Med Chem; 2014 Feb; 22(4):1459-67. PubMed ID: 24457088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural optimization of N
    Monforte AM; De Luca L; Buemi MR; Agharbaoui FE; Pannecouque C; Ferro S
    Bioorg Med Chem; 2018 Feb; 26(3):661-674. PubMed ID: 29291935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling, synthesis and biological evaluation of N-heteroaryl compounds as reverse transcriptase inhibitors against HIV-1.
    Singh A; Yadav D; Yadav M; Dhamanage A; Kulkarni S; Singh RK
    Chem Biol Drug Des; 2015 Mar; 85(3):336-47. PubMed ID: 25055732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 1,3-dihydro-benzimidazol-2-ones and their analogues as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Monforte AM; Logoteta P; De Luca L; Iraci N; Ferro S; Maga G; De Clercq E; Pannecouque C; Chimirri A
    Bioorg Med Chem; 2010 Feb; 18(4):1702-10. PubMed ID: 20097079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Design, synthesis and biologic evaluation of diarylbenzimidazole derivatives as novel HIV-1 non-nucleoside reverse transcriptase inhibitors].
    Qin BJ; Zhou T; Lu H; Jiang SB; Xie L
    Yao Xue Xue Bao; 2009 Nov; 44(11):1233-43. PubMed ID: 21355324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel N1-substituted 1,3-dihydro-2H-benzimidazol-2-ones as potent non-nucleoside reverse transcriptase inhibitors.
    Monforte AM; Rao A; Logoteta P; Ferro S; De Luca L; Barreca ML; Iraci N; Maga G; De Clercq E; Pannecouque C; Chimirri A
    Bioorg Med Chem; 2008 Aug; 16(15):7429-35. PubMed ID: 18585918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of novel nonnucleoside inhibitors of HIV-1 reverse transcriptase. 2-Aryl-substituted benzimidazoles.
    Roth T; Morningstar ML; Boyer PL; Hughes SH; Buckheit RW; Michejda CJ
    J Med Chem; 1997 Dec; 40(26):4199-207. PubMed ID: 9435891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis, and structure-activity relationships of 1,3-dihydrobenzimidazol-2-one analogues as anti-HIV agents.
    Monforte AM; Logoteta P; Ferro S; De Luca L; Iraci N; Maga G; Clercq ED; Pannecouque C; Chimirri A
    Bioorg Med Chem; 2009 Aug; 17(16):5962-7. PubMed ID: 19616956
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-based bioisosterism design, synthesis and biological evaluation of novel 1,2,4-triazin-6-ylthioacetamides as potent HIV-1 NNRTIs.
    Zhan P; Li X; Li Z; Chen X; Tian Y; Chen W; Liu X; Pannecouque C; De Clercq E
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7155-62. PubMed ID: 23084898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and anti-HIV activity of 4-(naphthalen-1-yl)-1,2,5-thiadiazol-3-hydroxyl derivatives.
    Rai D; Chen W; Zhan P; Liu H; Tian Y; Liang X; De Clercq E; Pannecouque C; Balzarini J; Liu X
    Chem Biol Drug Des; 2014 Oct; 84(4):420-30. PubMed ID: 24674646
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of novel 3-(3,5-dimethylbenzyl)uracil analogs as potential anti-HIV-1 agents.
    Sakakibara N; Hamasaki T; Baba M; Demizu Y; Kurihara M; Irie K; Iwai M; Asada E; Kato Y; Maruyama T
    Bioorg Med Chem; 2013 Sep; 21(18):5900-6. PubMed ID: 23916148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological evaluation of pyridazine derivatives as novel HIV-1 NNRTIs.
    Li D; Zhan P; Liu H; Pannecouque C; Balzarini J; De Clercq E; Liu X
    Bioorg Med Chem; 2013 Apr; 21(7):2128-34. PubMed ID: 23415090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular design, synthesis and biological evaluation of BP-O-DAPY and O-DAPY derivatives as non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Yang S; Pannecouque C; Daelemans D; Ma XD; Liu Y; Chen FE; De Clercq E
    Eur J Med Chem; 2013 Jul; 65():134-43. PubMed ID: 23707918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Searching for novel N
    Ferro S; Buemi MR; De Luca L; Agharbaoui FE; Pannecouque C; Monforte AM
    Bioorg Med Chem; 2017 Jul; 25(14):3861-3870. PubMed ID: 28559060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational strategies in discovering novel non-nucleoside inhibitors of HIV-1 RT.
    Barreca ML; Rao A; De Luca L; Zappalà M; Monforte AM; Maga G; Pannecouque C; Balzarini J; De Clercq E; Chimirri A; Monforte P
    J Med Chem; 2005 May; 48(9):3433-7. PubMed ID: 15857150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Docking and quantitative structure-activity relationship studies for the bisphenylbenzimidazole family of non-nucleoside inhibitors of HIV-1 reverse transcriptase.
    Lagos CF; Caballero J; Gonzalez-Nilo FD; David Pessoa-Mahana C; Perez-Acle T
    Chem Biol Drug Des; 2008 Nov; 72(5):360-9. PubMed ID: 19012572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and biological evaluation of novel 5-alkyl-2-arylthio-6-((3,4-dihydroquinolin-1(2H)-yl)methyl)pyrimidin-4(3H)-ones as potent non-nucleoside HIV-1 reverse transcriptase inhibitors.
    Zhang J; Zhan P; Wu J; Li Z; Jiang Y; Ge W; Pannecouque C; De Clercq E; Liu X
    Bioorg Med Chem; 2011 Jul; 19(14):4366-76. PubMed ID: 21683601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and anti-HIV-1 activity of 1-aromatic methyl-substituted 3-(3,5-dimethylbenzyl)uracil and N-3,5-dimethylbenzyl-substituted urea derivatives.
    Sakakibara N; Baba M; Okamoto M; Toyama M; Demizu Y; Misawa T; Kurihara M; Irie K; Kato Y; Maruyama T
    Antivir Chem Chemother; 2015 Feb; 24(1):3-18. PubMed ID: 26149262
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological evaluation of N-acetyl-beta-aryl-1,2-didehydroethylamines as new HIV-1 RT inhibitors in vitro.
    Cheng P; Jiang ZY; Wang RR; Zhang XM; Wang Q; Zheng YT; Zhou J; Chen JJ
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4476-80. PubMed ID: 17574419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and evaluation of N-aryl pyrrolidinones as novel anti-HIV-1 agents. Part 1.
    Wu B; Kuhen K; Ngoc Nguyen T; Ellis D; Anaclerio B; He X; Yang K; Karanewsky D; Yin H; Wolff K; Bieza K; Caldwell J; He Y
    Bioorg Med Chem Lett; 2006 Jul; 16(13):3430-3. PubMed ID: 16632349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.